The Global Tissue and Organ Transplantation Market to Witness Significant Growth Owing to Rising Prevalence of Organ Failure Worldwide The global tissue and organ transplantation market is estimated to be valued at USD 29.2 billion in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024-2030. Key Takeaways Key players operating in The Tissue And Organ Transplantation Market Size is Medtronic PLC, Zimmer Biomet, Novartis AG, Stryker Corporation, 21st Century Medicine, BiolifeSolutions, Inc. The rising geriatric population, growing awareness regarding transplantation benefits, and favourable government initiatives are presenting significant opportunities for market expansion. For instance, in 2023, the Indian government increased the insurance cover for organ transplant from Rs. 15 lakhs to Rs. 18 lakhs per patient to promote organ donation. Key players are expanding globally through partnerships, new product launches and acquisitions to capitalize on the availability of advanced treatments worldwide. In 2022, Medtronic acquired the medical device company Aleppo with an aim to strengthen its surgical robotics portfolio for transplantation surgeries. Market Drivers The Tissue And Organ Transplantation Market Size increasing prevalence of chronic health conditions requiring organ transplantation is a major market driver. As per statistics, around 1.5 million people worldwide are living with renal failure currently which is projected to rise over the coming years. Market Restraints Shortage of organ donors remains a significant challenge limiting the growth of this market. Per estimates, only 10% of the global need for organ transplants is met currently due to lower donation rates. This organ deficit hampers more widespread adoption of transplantation treatment. Get more insight onTissue and Organ Transplantation Market https://www.ukwebwire.com/tissue-and-organ-transplantation-market/